Next Article in Journal
Secondary Structural Model of MALAT1 Becomes Unstructured in Chronic Myeloid Leukemia and Undergoes Structural Rearrangement in Cervical Cancer
Next Article in Special Issue
Changes of the tRNA Modification Pattern during the Development of Dictyostelium discoideum
Previous Article in Journal
Exosomes in Immune Regulation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ncRNA
Volume 7
Issue 1
10.3390/ncrna7010005
ncrna-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction published on 21 November 2022, see Non-Coding RNA 2022, 8(6), 79.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma

by
Marina Tusup
1,2,
Phil F. Cheng
1,2,
Ernesto Picardi
3,4,
Austeja Raziunaite
1,2,
Reinhard Dummer
1,2,
Mitchell P. Levesque
1,2,
Lars E. French
1,2,5,
Emmanuella Guenova
1,2,6,
Thomas M. Kundig
1,2 and
Steve Pascolo
1,2,*
1
Department of Dermatology, University Hospital of Zürich, Gloriastrasse 31, 8091 Zürich, Switzerland
2
Faculty of Medicine, University of Zürich, 8091 Zürich, Switzerland
3
Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari “A. Moro”, 70121 Bari, Italy
4
Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council, 70126 Bari, Italy
5
Department of Dermatology and Allergy, University Hospital, LMU Munich, 80336 Munich, Germany
6
Department of Dermatology, Lausanne University Hospital and Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland
*
Author to whom correspondence should be addressed.
Non-Coding RNA 2021, 7(1), 5; https://doi.org/10.3390/ncrna7010005
Submission received: 18 September 2020 / Revised: 5 January 2021 / Accepted: 8 January 2021 / Published: 12 January 2021 / Corrected: 21 November 2022
(This article belongs to the Collection Research on RNA Modification)
Browse Figures
Versions Notes

Abstract

Background: RNA editing is a highly conserved posttranscriptional mechanism that contributes to transcriptome diversity. In mammals, it includes nucleobase deaminations that convert cytidine (C) into uridine (U) and adenosine (A) into inosine (I). Evidence from cancer studies indicates that RNA-editing enzymes promote certain mechanisms of tumorigenesis. On the other hand, recoding editing in mRNA can generate mutations in proteins that can participate in the Major Histocompatibility Complex (MHC) ligandome and can therefore be recognized by the adaptive immune system. Anti-cancer treatment based on the administration of immune checkpoint inhibitors enhance these natural anti-cancer immune responses. Results: Based on RNA-Seq datasets, we evaluated the editome of melanoma cell lines generated from patients pre- and post-immunotherapy with immune checkpoint inhibitors. Our results reveal a differential editing in Arthrobacter luteus (Alu) sequences between samples pre-therapy and relapses during therapy with immune checkpoint inhibitors. Conclusion: These data pave the way towards the development of new diagnostics and therapies targeted to editing that could help in preventing relapses during immunotherapies.
Keywords: editing; melanoma; ADAR; Alu sequences; immune checkpoint inhibitors; immunotherapy editing; melanoma; ADAR; Alu sequences; immune checkpoint inhibitors; immunotherapy

Share and Cite

MDPI and ACS Style

Tusup, M.; Cheng, P.F.; Picardi, E.; Raziunaite, A.; Dummer, R.; Levesque, M.P.; French, L.E.; Guenova, E.; Kundig, T.M.; Pascolo, S. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5. https://doi.org/10.3390/ncrna7010005

AMA Style

Tusup M, Cheng PF, Picardi E, Raziunaite A, Dummer R, Levesque MP, French LE, Guenova E, Kundig TM, Pascolo S. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA. 2021; 7(1):5. https://doi.org/10.3390/ncrna7010005

Chicago/Turabian Style

Tusup, Marina, Phil F. Cheng, Ernesto Picardi, Austeja Raziunaite, Reinhard Dummer, Mitchell P. Levesque, Lars E. French, Emmanuella Guenova, Thomas M. Kundig, and Steve Pascolo. 2021. "Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma" Non-Coding RNA 7, no. 1: 5. https://doi.org/10.3390/ncrna7010005

APA Style

Tusup, M., Cheng, P. F., Picardi, E., Raziunaite, A., Dummer, R., Levesque, M. P., French, L. E., Guenova, E., Kundig, T. M., & Pascolo, S. (2021). Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA, 7(1), 5. https://doi.org/10.3390/ncrna7010005

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop